Want to join the conversation?
$BIIB said that it launched BENEPALI, biosimilar version of Enbrel, in 1Q16 in six European countries. The company said that FLIXABI, biosimilar version of Remicade, received a positive opinion from Committee for Medicinal Products for Human Use, and is waiting approval from European Commission.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!